Answer
Hydroxycarbamide medac is indicated for chronic myeloid leukaemia in the chronic or accelerated phase, and essential thrombocythaemia or polycythaemia vera with a high risk of thromboembolic complications.
Sources for this answer
- Hydroxycarbamide medac 500 mg capsule, hardmedac Pharma LLP · emc · SmPC §4.1 Therapeutic Indications · Version 14Document updated
Sources checked